Mitochondrial Diseases and Genetic Defects of Atp Synthase.
From: Institute of Physiology and Centre for Applied Genomics, Academy of Sciences of the Czech Republic, Vídenská 1083, CZ 142 20 Prague, Czech Republic. houstek@biomed.cas.cz
Biochimica et biophysica acta
- Publish Date:
- ISSN: 0006-3002
- Volume: 1757
- Issue: 9-10
- Pages: 1400-5
- Medium: Print
- Language: English
- Citation (JAMA): Houstek Josef, Pícková Andrea, Vojtísková Alena, et al. Mitochondrial Diseases and Genetic Defects of Atp Synthase.. Biochim. Biophys. Acta ;1757:1400-5
Abstract
ATP synthase is a key enzyme of mitochondrial energy conversion. In mammals, it produces most of cellular ATP. Alteration of ATP synthase biogenesis may cause two types of isolated defects: qualitative when the enzyme is structurally modified and does not function properly, and quantitative when it is present in insufficient amounts. In both cases the cellular energy provision is impaired, and diminished use of mitochondrial DeltamuH+ promotes ROS production by the mitochondrial respiratory chain. The primary genetic defects have so far been localized in mtDNA ATP6 gene and nuclear ATP12 gene, however, involvement of other nuclear genes is highly probable.
Mesh Headings (Keywords): Animals, Humans, Mitochondrial Diseases, Mitochondrial Proton-Translocating ATPases, Reactive Oxygen Species
Check for Full Text / PubMed Unique Identifier (PMID): 16730639
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.